Who manufactures Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial?

BioNTech Manufacturing GmbH (BE)

What ATC class does Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial belong to?

Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial: ATC J07BN01 Covid-19, RNA-based Vaccine. ATC is the WHO Anatomical Therapeutic Chemical classification.

OTC

Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial

Q: What pharmaceutical form is Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial available in?

Comirnaty KP.2 30 µg/dose inj. disp. i.m. vial: Dispersion for injection (Intramuscular use)

Dispersion for injection

INN: Cemivameran, COVID-19 mRNA Vaccine (nucleoside modified)

Data updated: 2026-05-12

Saatavilla maissa:

🇩🇪🇬🇧

Muoto

Dispersion for injection

Annostus

—

Antotapa

Intramuscular use

Säilytys

—

Tietoa tuotteesta

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.